SHARE-BASED COMPENSATION (Details) (USD $) | 3 Months Ended | 9 Months Ended | | |
Sep. 27, 2014 | Sep. 28, 2013 | Sep. 27, 2014 | Sep. 28, 2013 | Sep. 27, 2014 | Sep. 27, 2014 | 4-May-12 | 4-May-12 | 4-May-12 | Apr. 24, 2009 | Apr. 24, 2009 | Apr. 24, 2009 |
Options | Awards | 2012 Stock Plan | 2012 Stock Plan | 2012 Stock Plan | 2009 Stock Plan | 2009 Stock Plan | 2009 Stock Plan |
| | | Options | Employee Stock/Stock Unit Award | | Options | Awards |
Share-based Compensation | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Authorized shares | ' | ' | ' | ' | ' | ' | 2,400,000 | 1,680,000 | 720,000 | 4,400,000 | 3,200,000 | 1,200,000 |
Fair Value Assumptions | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Risk-free interest rate (as a percent) | ' | ' | 1.68% | 1.03% | ' | ' | ' | ' | ' | ' | ' | ' |
Dividend yield (as a percent) | ' | ' | 0.70% | 0.89% | ' | ' | ' | ' | ' | ' | ' | ' |
Volatility factor (as a percent) | ' | ' | 38.70% | 39.40% | ' | ' | ' | ' | ' | ' | ' | ' |
Expected term (in years) | ' | ' | '5 years 7 months 6 days | '6 years | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeiture rate (as a percent) | ' | ' | 3.81% | 4.52% | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Option Plans Activity and Related Information | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding beginning of period, shares | ' | ' | 1,476,000 | 2,184,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding beginning of period, weighted-average exercise price (in dollars per share) | ' | ' | $19.01 | $16.69 | ' | ' | ' | ' | ' | ' | ' | ' |
Granted, shares | 0 | 0 | 115,000 | 176,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Granted, weighted-average exercise price (in dollars per share) | ' | ' | $42.24 | $32.53 | ' | ' | ' | ' | ' | ' | ' | ' |
Exercised, shares | ' | ' | -76,000 | -807,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Exercised, weighted-average exercise price (in dollars per share) | ' | ' | $17.68 | $16.06 | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited, shares | ' | ' | -4,000 | -4,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited, weighted-average exercise price (in dollars per share) | ' | ' | $27.12 | $14.37 | ' | ' | ' | ' | ' | ' | ' | ' |
Expired, shares | ' | ' | -17,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' |
Expired, weighted-average exercise price (in dollars per share) | ' | ' | $16.34 | $0 | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding end of period, shares | 1,494,000 | 1,549,000 | 1,494,000 | 1,549,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding end of period, weighted-average exercise price (in dollars per share) | $20.88 | $18.83 | $20.88 | $18.83 | ' | ' | ' | ' | ' | ' | ' | ' |
Expected to vest after applying forfeiture rate, shares | 1,479,000 | 1,527,000 | 1,479,000 | 1,527,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Expected to vest after applying forfeiture rate, weighted-average exercise price (in dollars per share) | $20.73 | $18.68 | $20.73 | $18.68 | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable end of period, shares | 1,180,000 | 1,017,000 | 1,180,000 | 1,017,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable end of period, weighted-average exercise price (in dollars per share) | $17.69 | $15.43 | $17.69 | $15.43 | ' | ' | ' | ' | ' | ' | ' | ' |
Summary of Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding end of period, weighted-average remaining contractual term (in years) | ' | ' | '5 years 4 months 24 days | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding end of period, aggregate intrinsic value (in dollars) | $22,234,000 | ' | $22,234,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected to vest after applying forfeiture rate, weighted-average remaining contractual term (in years) | ' | ' | '5 years 4 months 9 days | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected to vest after applying forfeiture rate, aggregate intrinsic value (in dollars) | 22,184,000 | ' | 22,184,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable end of period, weighted-average remaining contractual term (in years) | ' | ' | '4 years 7 months 6 days | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable end of period, aggregate intrinsic value (in dollars) | 20,689,000 | ' | 20,689,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intrinsic value of options exercised (in dollars) | ' | ' | 1,800,000 | 14,600,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Total unrecognized compensation cost related to nonvested share-based compensation (in dollars) | ' | ' | ' | ' | $1,800,000 | $9,800,000 | ' | ' | ' | ' | ' | ' |
Total unrecognized compensation cost, recognized over a weighted-average period (in years) | ' | ' | ' | ' | '2 years 5 months 12 days | '2 years 5 months 23 days | ' | ' | ' | ' | ' | ' |
Stock/Stock Unit Award Activity and Related Information | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at beginning of period, shares | ' | ' | 551,000 | 458,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at beginning of period, weighted-average grant date fair value (in dollars per share) | ' | ' | $24.75 | $20.90 | ' | ' | ' | ' | ' | ' | ' | ' |
Awarded, shares | ' | ' | 208,000 | 165,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Awarded, weighted-average grant date fair value (in dollars per share) | ' | ' | $42.39 | $32.90 | ' | ' | ' | ' | ' | ' | ' | ' |
Vested, shares | ' | ' | -124,000 | -62,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Vested, weighted-average grant date fair value (in dollars per share) | ' | ' | $16.76 | $18.86 | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited, shares | ' | ' | -65,000 | -6,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited, weighted-average grant date fair value (in dollars per share) | ' | ' | $28.79 | $20.05 | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at end of period, shares | 570,000 | 555,000 | 570,000 | 555,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested at the end of period, weighted-average grant date fair value (in dollars per share) | $32.46 | $24.70 | $32.46 | $24.70 | ' | ' | ' | ' | ' | ' | ' | ' |